Firat Duru is an expert in Cardiology at University Hospital of Zurich (Switzerland). As of October 2026, ScienceLeadR ranks Firat Duru in the top 1% of experts worldwide for Cardiomyopathies, Cardiovascular Abnormalities and Congenital Abnormalities. Firat Duru has authored 564 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 1,681 (community average: 125). How the SLR is computed.

LeadR Profile

Firat Duru University Hospital of Zurich Switzerland
1 681 ScienceLeadR Reputation 1681
Network Map

Cardiology

Subspecialties: Public Health - Genetics - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026

Source: PubMed

University Hospital of Zurich

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 564

Citations

Citations: 23 403 1st author: 35 Last author: 109 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Association of exercise with phenotype and arrhythmic outcomes in gene-elusive arrhythmogenic cardiomyopathy.
PMID 42933878 — exercise, genes, cardiovascular diseases, phenotype, cardiomyopathies
Open Heart20260
Tricuspid regurgitation and outcomes in arrhythmogenic right ventricular cardiomyopathy: role of tricuspid annulus dilatation.
PMID 42669127 — cardiology, arrhythmogenic right ventricular dysplasia, tricuspid valve insufficiency, cardiomyopathies
Eur Heart J Top journal20261
Desmoplakin Mutations in Cardiac Fibroblasts Cause TGFβ1-Mediated Pathological Fibrogenesis in Desmoplakin Cardiomyopathy Via Beclin-1 Regulation.
PMID 42615127 — cells, genes, autophagy, fibrosis, heart, desmoplakins, cardiovascular system, phenotype, collagen, beclin-1, fibroblasts, mutation, cardiomyopathies, endocytosis
Circ Res20260
Reclassification of Exercise-Induced Arrhythmogenic Cardiomyopathy: Detection of a Pathogenic PKP2 Variant in a Male Athlete.
PMID 42283673 — exercise, research design, genes, genetic testing, athletes, cardiomyopathies
JACC Case Rep20260
Arrhythmogenic right ventricular cardiomyopathy.
PMID 42244336 — cardiology, arrhythmogenic right ventricular dysplasia, cardiomyopathies
Eur Heart J Top journal20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 1 1

By status:

Completed 2
Recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 4
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia a Single Center Phase II Clinical Trial
NCT05594368 — radiotherapy, tachycardia, ventricular, arrhythmias, cardiac, multiple chronic conditions, tachycardia, therapeutics, catheter ablation, catheters
Phase 1Recruiting2022

LeadR Networks

Main global connection map